News
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
1d
The New Times on MSNIVI Africa’s Ndembi on Rwanda’s role in vaccine innovation and health securityA Cabinet meeting chaired by President Paul Kagame on June 9th, 2025, approved Prof. Nicaise Ndembi, Deputy Director General of the International Vaccine Institute (IVI), as the IVI Regional Director ...
State Surgeon General Dr. Joseph Ladapo is speaking to the community about the updated federal recommendations for healthy ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.
I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...
StockStory.org on MSN7d
Why Moderna (MRNA) Stock Is Falling TodayWhat Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The mass layoffs of federal employees have been unprecedented, devastating, and chaotic but it is the cuts to HHS that are ...
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...
The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...
Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results